09/21/2023 3:15 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:28 PM | G1 Therapeutics (Subject) Velleca Mark A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 5:50 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/07/2023 3:07 PM | Bailey John E. Jr. (0001806147) (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:08 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:08 PM | G1 Therapeutics (Issuer) MURDOCK TERRY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:08 PM | G1 Therapeutics (Issuer) Perry Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/16/2023 3:07 PM | Flowers Cynthia Louise (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:07 PM | G1 Therapeutics (Issuer) Sharpless Norman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 3:34 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2023 3:41 PM | G1 Therapeutics (Issuer) Thomas Monica R. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/12/2023 3:19 PM | G1 Therapeutics (Issuer) Perry Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 3:19 PM | G1 Therapeutics (Issuer) Umstead John V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 3:19 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 3:20 PM | Avagliano Mark (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 3:20 PM | G1 Therapeutics (Issuer) MURDOCK TERRY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2023 3:16 PM | Bailey John E. Jr. (0001806147) (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 5:46 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2023 3:20 PM | G1 Therapeutics (Filer)
| Form 10-K/A | |
03/01/2023 5:37 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2023 5:30 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/03/2023 10:47 AM | G1 Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2023 5:39 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2023 7:23 PM | Bailey John E. Jr. (0001806147) (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:25 PM | G1 Therapeutics (Issuer) Hanson James S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:25 PM | Avagliano Mark (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:25 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:25 PM | G1 Therapeutics (Issuer) Perry Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:26 PM | G1 Therapeutics (Issuer) MURDOCK TERRY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2023 7:26 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2022 3:12 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2022 9:35 AM | G1 Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
11/17/2022 3:04 PM | G1 Therapeutics (Filer)
| Form 424B5 | |
11/02/2022 3:15 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2022 5:45 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2022 3:05 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |